GSK plc
British multinational pharmaceutical company founded in 2000, known for pharmaceuticals, vaccines, and consumer healthcare products, headquartered in London, United Kingdom.
Company Type
public
Founded
2000
Headquarters
London, United Kingdom
Stock
London Stock Exchange, NYSE: GSK
Revenue
approximately GBP 30 billion (FY2024)
Employees
approximately 70,000
Primary Market
Global
About GSK plc
British multinational pharmaceutical company founded in 2000, known for pharmaceuticals, vaccines, and consumer healthcare products, headquartered in London, United Kingdom.
History of GSK plc
GSK was founded in 2000 through the merger of Glaxo Wellcome and SmithKline Beecham. Glaxo Wellcome was formed through the merger of Glaxo and Wellcome in 1995. SmithKline Beecham was formed through the merger of SmithKline Beckman and Beecham in 1989. The merger created one of the world's largest pharmaceutical companies with a broad portfolio of pharmaceuticals, vaccines, and consumer healthcare products.
The company grew through research and development and acquisitions in the 2000s. GSK expanded its pharmaceutical portfolio and vaccine capabilities. The company also invested in emerging markets to capture growth opportunities. GSK faced challenges including patent expirations on key drugs and regulatory scrutiny.
In 2018, GSK announced plans to spin off its consumer healthcare business to create a focused pharmaceutical and vaccine company. The consumer healthcare business included brands such as Sensodyne, Advil, and Centrum. The spinoff was completed in July 2022, creating Haleon as an independent publicly traded company.
Following the spinoff, GSK focused on pharmaceuticals and vaccines. The company invested in research and development for new medicines and vaccines. GSK also focused on operational efficiency and cost management. The company has faced challenges including legal disputes over the Zantac drug and regulatory issues.
Recent strategic direction has focused on pharmaceutical innovation and vaccine development. GSK has invested in research and development for new medicines in therapeutic areas including oncology and immunology. The company has also focused on vaccine development for infectious diseases. GSK continues to develop new pharmaceuticals and vaccines to maintain its market leadership.
Brands Owned by GSK plc
GSK plc owns 1 brand in our database.
Shop GSK plc Brands
Disclosure: We may earn commission from purchases
Stock Information
Jobs at GSK plc
Latest News About GSK plc
Related Articles About GSK plc
View more articles
Monthly IPO Roundup: July 2026 — June's Biggest Listings
June 2026 was the most historic IPO month in market history: SpaceX priced at $135 per share on June 12, raising $75 billion in the largest IPO ever. Quantinuum raised $1.68B, INNIO priced a $2.8B deal, and Bending Spoons filed for a $20B Nasdaq listing. Full recap.
Monthly M&A Roundup: June 2026 Brand Ownership Changes
June 2026's biggest brand ownership moves: Berkshire Hathaway agreed to buy Taylor Morrison for $6.8B, GSK struck a $10.6B deal for Nuvalent, CRH acquired Arcosa for $8.5B, and Qualcomm agreed to buy AI startup Modular for $3.92B. Full breakdown of every major deal.
A Complete Guide to LVMH Brands: What Does the Luxury Giant Own?
LVMH owns 75 luxury maisons including Louis Vuitton, Dior, Tiffany, Guerlain, and Sephora. Here is the complete brand list by division, with acquisition dates and what each brand does.
Related Companies to GSK plc
View more companies
Haleon plc
British consumer healthcare company and the world's largest pure-play consumer health business, owning Sensodyne, Panadol, Centrum, Advil, Voltaren, and other global healthcare brands.
6 brands in portfolio
Unilever plc
British consumer goods company transitioning to a pure-play HPC business. Owns Dove, Axe, Vaseline, Domestos, and 400+ personal care and home care brands sold in 190 countries.
25 brands in portfolio
Colgate-Palmolive Company
American multinational consumer products company specializing in oral care, personal care, home care, and pet nutrition products.
8 brands in portfolio
The Estée Lauder Companies Inc.
American multinational prestige beauty company owning Estee Lauder, Clinique, MAC, La Mer, Jo Malone London, Aveda, and other luxury beauty brands, publicly traded on the NYSE.
9 brands in portfolio
Johnson & Johnson
American multinational pharmaceutical and consumer goods company specializing in healthcare products, medical devices, and pharmaceuticals.
15 brands in portfolio
L'Oréal S.A.
French multinational beauty company and the world's largest cosmetics company by revenue, owning brands including L'Oréal Paris, Lancôme, Garnier, Maybelline, CeraVe, La Roche-Posay, and Kérastase.
8 brands in portfolio